What is ISoP?
The International Society of Pharmacovigilance (ISoP) is an international non-profit scientific organisation, which aims to foster Pharmacovigilance both scientifically and educationally, and enhance all aspects of the safe and proper use of medicines, in all countries. more…
COVID-19 Information
PSD 2020
ISoP Webinar
ISoP Seminar 2020
10-11 December 2020
Intelligent Automation in Pharmacovigilance.
READ MORE
ISoP-UMC
ISoP-UMC Training
China
Pharmacovigilance systems in China: Moving to the next step.
ISoP Chapters Activities
Israel Chapter Webinar series
2 September 2020
READ MORE
Africa Chapter meeting
3 September 2020
Western Pacific Chapter meeting
7 September 2020
READ MORE
ISoP Training
ISoP Symposium & Training
Moscow, Russia, Spring 2021
Please note important information
Moving Pharmacovigilance Forward in the Eurasian Economic Union (EAEU)
REGISTER NOW
ISoP 2021
Annual Meeting
Muscat, Oman, 11-14 October 2021
Please note important information
Integrated Pharmacovigilance for Safer Patients
READ MORE
What’s New
ISoP General Assembly 14/10/20, 18.00 UTC (by video-conference)
Article published by NZ Pharmacy Today magazine about World Pharmacist Day and the ISoP statement in support of pharmacists worldwide
ISoP statement in support of World Pharmacist Day, 25 September 2020
New ISoP infographic ‘Using Medicines Safely during the COVID-19 pandemic’
COVID-19 Information
ISoP President’s message
ISoP editorials in Drug Safety journal
CIOMS Establishes Annual Award for Medical Students
ISoP Advisory Board 2019-2022
Updated ISoP Privacy Policy
In line with the General Data Protection Regulation (GDPR)
ISoP Latest
President of ISoP
I am honoured and delighted to have been elected as President of ISoP – as announced on 28th October 2019 at our Annual General Meeting in Bogota – and am especially proud to be the first woman to ever hold this role in our professional society.
Mira Harrison‐Woolrych
President – International Society of Pharmacoviliance
Drug Safety
ISoP Official Journal
Drug Safety is the premier international journal covering the disciplines of pharmacovigilance, pharmacoepidemiology, benefit-risk assessment and risk management.